{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:03:23Z","timestamp":1753891403500,"version":"3.41.2"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["23JRRA715"],"award-info":[{"award-number":["23JRRA715"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Influenza epidemics represent a significant threat to global public health, primarily caused by the influenza viruses A and B. Although antiviral drugs targeting the influenza virus, such as zanamivir and oseltamivir, are clinically available, the emergence of virus evolution and drug resistance necessitates the development of host-directed therapies. Protein kinases are essential components of host signaling pathways, including the orchestration of virus\u2013host interactions. By screening a library of kinase inhibitors, we identified that OTS167, a pharmacological inhibitor of maternal embryonic leucine zipper kinase (MELK), strongly inhibits the infections caused by multiple influenza virus subtypes in cell culture. This antiviral activity was further confirmed by treatment with another MELK pharmacological inhibitor, MELK-8a, and siRNA-mediated MELK gene silencing. In mice challenged with the influenza A virus, treatment with OTS167 inhibited both viral replication and lung inflammation. Mechanistically, inhibition of MELK by OTS167 downregulates the downstream effector CDK1, thereby inhibiting influenza virus M1 mRNA splicing to reduce viral replication and virus particle assembly. Finally, we demonstrated that combining OTS167 with zanamivir or oseltamivir resulted in additive antiviral activity. In conclusion, we identified MELK as a crucial host kinase that supports the influenza virus infection. OTS167, a pharmacological inhibitor of MELK currently undergoing phase II clinical trials for treating cancer, potently inhibits influenza virus infections <jats:italic>in vitro<\/jats:italic> and in mice, representing a promising lead for developing novel influenza antivirals.<\/jats:p>","DOI":"10.3389\/fmicb.2025.1600935","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T05:28:48Z","timestamp":1749101328000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening kinase inhibitors identifies MELK as a prime target against influenza virus infections through inhibition of viral mRNA splicing"],"prefix":"10.3389","volume":"16","author":[{"given":"Xuanye","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xili","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lele","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongren","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","article-title":"Mitogen-activated protein kinases in innate immunity","volume":"13","author":"Arthur","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"716469","DOI":"10.3389\/fimmu.2021.716469","article-title":"NF-\u03baB: at the borders of autoimmunity and inflammation","volume":"12","author":"Barnabei","year":"2021","journal-title":"Front. Immunol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"104823","DOI":"10.1016\/j.antiviral.2020.104823","article-title":"Drug screening identifies gemcitabine inhibiting rotavirus through alteration of pyrimidine nucleotide synthesis pathway","volume":"180","author":"Chen","year":"2020","journal-title":"Antivir. Res."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"18171","DOI":"10.18632\/oncotarget.7685","article-title":"Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor","volume":"7","author":"Chung","year":"2016","journal-title":"Oncotarget"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"105868","DOI":"10.1016\/j.antiviral.2024.105868","article-title":"Caffeic acid phenethyl ester: an effective antiviral agent against porcine reproductive and respiratory syndrome virus","volume":"225","author":"Cui","year":"2024","journal-title":"Antivir. Res."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e0119223","DOI":"10.1128\/jvi.01192-23","article-title":"Unveiling the role of host kinases at different steps of influenza A virus life cycle","volume":"98","author":"Dey","year":"2024","journal-title":"J. Virol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e00070-14","DOI":"10.1128\/mBio.00070-14","article-title":"Influenza viruses and mRNA splicing: doing more with less","volume":"5","author":"Dubois","year":"2014","journal-title":"mBio"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.tig.2013.05.010","article-title":"Human housekeeping genes, revisited","volume":"29","author":"Eisenberg","year":"2013","journal-title":"Trends Genet."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"105870","DOI":"10.1016\/j.antiviral.2024.105870","article-title":"Glucocorticoid receptor and specificity protein 1 (Sp1) or Sp3, but not the antibiotic mithramycin A, stimulates human alphaherpesvirus 1 (HSV-1) replication","volume":"225","author":"el-Mayet","year":"2024","journal-title":"Antivir. Res."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40169-014-0045-y","article-title":"MELK\u2014a conserved kinase: functions, signaling, cancer, and controversy","volume":"4","author":"Ganguly","year":"2015","journal-title":"Clin. Transl. Med."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1056\/NEJMoa2414610","article-title":"Highly pathogenic avian influenza A(H5N1) virus infections in humans","volume":"392","author":"Garg","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1172\/JCI76094","article-title":"Targeting cancer with kinase inhibitors","volume":"125","author":"Gross","year":"2015","journal-title":"J. Clin. Invest."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e0078622","DOI":"10.1128\/jvi.00786-22","article-title":"PSMD12-mediated M1 ubiquitination of influenza A virus at K102 regulates viral replication","volume":"96","author":"Hui","year":"2022","journal-title":"J. Virol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"Synergy finder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1016\/j.celrep.2017.11.033","article-title":"MELK promotes melanoma growth by stimulating the NF-\u03baB pathway","volume":"21","author":"Janostiak","year":"2017","journal-title":"Cell Rep."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1056\/NEJMc2415890","article-title":"Critical illness in an adolescent with influenza A(H5N1) virus infection","volume":"392","author":"Jassem","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1002\/jmv.26990","article-title":"A brief review of influenza virus infection","volume":"93","author":"Javanian","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref18","first-page":"2229","article-title":"A high throughput RNAi screen reveals determinants of HIV-1 activity in host kinases","volume":"7","author":"Jiang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature08760","article-title":"Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication","volume":"463","author":"Karlas","year":"2010","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/rmv.722","article-title":"Phosphorylation events during viral infections provide potential therapeutic targets","volume":"22","author":"Keating","year":"2012","journal-title":"Rev. Med. Virol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.adv2422","article-title":"Why hasn\u2019t the bird flu pandemic started?","volume":"386","author":"Kupferschmidt","year":"2024","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"16410","DOI":"10.1073\/pnas.0907439106","article-title":"A genome-wide genetic screen for host factors required for hepatitis C virus propagation","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.drudis.2019.01.018","article-title":"Repurposing host-based therapeutics to control coronavirus and influenza virus","volume":"24","author":"Li","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41401-018-0030-x","article-title":"Anti-influenza effect and action mechanisms of the chemical constituent gallocatechin-7-gallate from Pithecellobium clypearia Benth","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2223057","DOI":"10.1080\/21505594.2023.2223057","article-title":"Pathogenicity and virulence of influenza","volume":"14","author":"Liang","year":"2023","journal-title":"Virulence"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41408-019-0249-x","article-title":"Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma","volume":"9","author":"Maes","year":"2019","journal-title":"Blood Cancer J."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/v11020171","article-title":"Influenza virus infections and cellular kinases","volume":"11","author":"Meineke","year":"2019","journal-title":"Viruses"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e9332","DOI":"10.1371\/journal.pone.0009332","article-title":"Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro","volume":"5","author":"Nguyen","year":"2010","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"111152","DOI":"10.1016\/j.jtbi.2022.111152","article-title":"Maternal embryonic leucine zipper kinase (MELK) optimally regulates the HIV-1 uncoating process","volume":"545","author":"Nishiyama","year":"2022","journal-title":"J. Theor. Biol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1021\/acsinfecdis.9b00230","article-title":"An influenza virus entry inhibitor targets class II PI3 kinase and synergizes with oseltamivir","volume":"5","author":"O\u2019Hanlon","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1006\/bbrc.1998.9247","article-title":"cdc2 kinase-mediated phosphorylation of splicing factor SF2\/ASF","volume":"249","author":"Okamoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2217\/imt.10.99","article-title":"Small-molecule protein kinase inhibitors and their effects on the immune system: implications for cancer treatment","volume":"3","author":"Ott","year":"2011","journal-title":"Immunotherapy"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"107059","DOI":"10.1016\/j.phrs.2024.107059","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update","volume":"200","author":"Roskoski","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jiac.2021.11.014","article-title":"Comparative effectiveness of neuraminidase inhibitors in patients with influenza: a systematic review and network meta-analysis","volume":"28","author":"Su","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s12094-024-03664-5","article-title":"Targeting MELK in tumor cells and tumor microenvironment: from function and mechanism to therapeutic application","volume":"27","author":"Su","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1124\/pharmrev.121.000410","article-title":"Looking under the lamppost: the search for new cancer targets in the human kinome","volume":"74","author":"Sueca-Comes","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1074\/jbc.M703988200","article-title":"Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening","volume":"283","author":"Supekova","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e1006441","DOI":"10.1371\/journal.ppat.1006441","article-title":"Phosphorylation of the HIV-1 capsid by MELK triggers uncoating to promote viral cDNA synthesis","volume":"13","author":"Takeuchi","year":"2017","journal-title":"PLoS Pathog."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1021\/acs.jmedchem.6b00052","article-title":"Toward the validation of maternal embryonic leucine zipper kinase: discovery, optimization of highly potent and selective inhibitors, and preliminary biology insight","volume":"59","author":"Tour\u00e9","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e1003460","DOI":"10.1371\/journal.ppat.1003460","article-title":"Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing","volume":"9","author":"Tsai","year":"2013","journal-title":"PLoS Pathog."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1056\/NEJMc2405371","article-title":"Highly pathogenic avian influenza A(H5N1) virus infection in a dairy farm worker","volume":"390","author":"Uyeki","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"8642","DOI":"10.1074\/jbc.M311466200","article-title":"Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1","volume":"279","author":"Vulsteke","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2301242","DOI":"10.1080\/21505594.2023.2301242","article-title":"Immunosuppressants exert antiviral effects against influenza A(H1N1)pdm09 virus via inhibition of nucleic acid synthesis, mRNA splicing, and protein stability","volume":"15","author":"Wang","year":"2024","journal-title":"Virulence"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"105558","DOI":"10.1016\/j.antiviral.2023.105558","article-title":"CDK4\/6 inhibitor palbociclib promotes SARS-CoV-2 cell entry by down-regulating SKP2 dependent ACE2 degradation","volume":"212","author":"Xiao","year":"2023","journal-title":"Antivir. Res."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.bbadis.2014.04.017","article-title":"Regulatory roles of c-jun in H5N1 influenza virus replication and host inflammation","volume":"1842","author":"Xie","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"105635","DOI":"10.1016\/j.antiviral.2023.105635","article-title":"Artesunate inhibits PDE4 leading to intracellular cAMP accumulation, reduced ERK\/MAPK signaling, and blockade of influenza A virus vRNP nuclear export","volume":"215","author":"Yang","year":"2023","journal-title":"Antivir. Res."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-020-0082-8","article-title":"Kinase inhibition in autoimmunity and inflammation","volume":"20","author":"Zarrin","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"105296","DOI":"10.1016\/j.antiviral.2022.105296","article-title":"The CDK1 inhibitor, Ro-3306, is a potential antiviral candidate against influenza virus infection","volume":"201","author":"Zhao","year":"2022","journal-title":"Antivir. Res."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1600935\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T05:28:51Z","timestamp":1749101331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1600935\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":49,"alternative-id":["10.3389\/fmicb.2025.1600935"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1600935","relation":{},"ISSN":["1664-302X"],"issn-type":[{"type":"electronic","value":"1664-302X"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"article-number":"1600935"}}